These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38000893)

  • 1. Extraction outcomes of implantable cardioverter-defibrillator leads vary by manufacturer and model family.
    Hayashi K; Callahan T; Rickard J; Younis A; Baranowski B; Martin D; Nakhla S; Tabaja C; Wilkoff BL
    Europace; 2023 Dec; 25(12):. PubMed ID: 38000893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of outcomes and required tools between transvenous extraction of pacemaker and implantable cardioverter defibrillator leads: Insight from single high-volume center experience.
    Hayashi K; Callahan T; Rickard J; Baranowski B; Martin DO; Nakhla S; Tabaja C; Paul A; Wilkoff BL
    J Cardiovasc Electrophysiol; 2024 Jul; 35(7):1382-1392. PubMed ID: 38725252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical predictors of adverse patient outcomes in an experience of more than 5000 chronic endovascular pacemaker and defibrillator lead extractions.
    Brunner MP; Cronin EM; Duarte VE; Yu C; Tarakji KG; Martin DO; Callahan T; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
    Heart Rhythm; 2014 May; 11(5):799-805. PubMed ID: 24444444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.
    Brunner MP; Cronin EM; Jacob J; Duarte VE; Tarakji KG; Martin DO; Callahan T; Borek PP; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
    Heart Rhythm; 2013 Oct; 10(10):1444-50. PubMed ID: 23816440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transvenous lead extraction of implantable cardioverter-defibrillators: A comprehensive outcome-and risk factor analysis.
    Chung DU; Burger H; Kaiser L; Osswald B; Bärsch V; Nägele H; Knaut M; Reichenspurner H; Gessler N; Willems S; Butter C; Pecha S; Hakmi S;
    Pacing Clin Electrophysiol; 2023 Aug; 46(8):815-823. PubMed ID: 37461858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanical extraction of implantable cardioverter-defibrillator leads with a dwell time of more than 10 years: insights from a single high-volume centre.
    Ząbek A; Boczar K; Ulman M; Holcman K; Kostkiewicz M; Pfitzner R; Dębski M; Musiał R; Lelakowski J; Małecka B
    Europace; 2023 Mar; 25(3):1100-1109. PubMed ID: 36660771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical predictors of incomplete coronary sinus lead removal during transvenous lead extraction in patients with cardiac resynchronization therapy.
    Hayashi K; Younis A; Callahan T; Baranowski B; Martin DO; Nakhla S; Wilkoff BL
    Heart Rhythm; 2023 Jun; 20(6):872-878. PubMed ID: 36933853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance and outcome of the subcutaneous implantable cardioverter-defibrillator after transvenous lead extraction.
    Chung DU; Tauber J; Kaiser L; Schlichting A; Pecha S; Sinning C; Rexha E; Reichenspurner H; Willems S; Gosau N; Hakmi S
    Pacing Clin Electrophysiol; 2021 Feb; 44(2):247-257. PubMed ID: 33377195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of transvenous lead extraction of leads older than 20 years.
    Issa ZF
    J Cardiovasc Electrophysiol; 2021 Nov; 32(11):3042-3048. PubMed ID: 34453369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of transvenous extraction of single- versus dual-coil implantable cardioverter-defibrillator leads at single-center experience.
    Ząbek A; Boczar K; Dębski M; Ulman M; Pfitzner R; Musiał R; Lelakowski J; Małecka B
    Medicine (Baltimore); 2019 Jul; 98(30):e16548. PubMed ID: 31348275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence and extraction of implantable cardioverter-defibrillator leads with conductor externalization.
    Maciąg A; Syska P; Sterliński M; Kołodzińska A; Oręziak A; Kuśmierski K; Marciniak-Emmons M; Przybylski A; Szumowski Ł; Opolski G; Szwed H
    Cardiol J; 2018; 25(2):221-228. PubMed ID: 28840589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of patients requiring emergent surgical or endovascular intervention for catastrophic complications during transvenous lead extraction.
    Brunner MP; Cronin EM; Wazni O; Baranowski B; Saliba WI; Sabik JF; Lindsay BD; Wilkoff BL; Tarakji KG
    Heart Rhythm; 2014 Mar; 11(3):419-25. PubMed ID: 24315967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transvenous extraction of advisory implantable cardioverter defibrillator leads with a relatively long implant duration.
    Goya M; Nagashima M; Hiroshima KI; Hayashi K; Makihara Y; Fukunaga M; An Y; Ohe M; Sasaki T; Shiohira S; Shirai Y; Kawabata M; Ando K; Isobe M; Hirao K
    J Cardiol; 2018 Oct; 72(4):316-320. PubMed ID: 29705082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomogram for predicting 30-day all-cause mortality after transvenous pacemaker and defibrillator lead extraction.
    Brunner MP; Yu C; Hussein AA; Tarakji KG; Wazni OM; Kattan MW; Wilkoff BL
    Heart Rhythm; 2015 Dec; 12(12):2381-6. PubMed ID: 26190318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transvenous lead extraction in patients with prior extraction procedures: Procedural profiles and outcomes.
    Hutt E; Diab M; Wazni OM; Kaur S; Tarakji KG; Saliba WI; Kanj M; Cantillon D; Rickard J; Varma N; Callahan T; Martin DO; Niebauer M; Dresing T; Chung M; Wilkoff BL; Hussein AA
    Heart Rhythm; 2020 Nov; 17(11):1904-1908. PubMed ID: 32512177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and effectiveness of transvenous extraction of pacemaker and implantable cardioverter-defibrillator leads in patients under or over 80 years of age.
    Kempa M; Budrejko S; Piepiorka M; Rogowski J; Raczak G; Kozłowski D
    Kardiol Pol; 2013; 71(2):130-5. PubMed ID: 23575705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transvenous lead extraction in 1000 patients guided by intraprocedural risk stratification without surgical backup.
    Issa ZF
    Heart Rhythm; 2021 Aug; 18(8):1272-1278. PubMed ID: 33781982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transvenous Extraction of Pacemaker and Defibrillator Leads and the Risk of Tricuspid Valve Regurgitation.
    Park SJ; Gentry JL; Varma N; Wazni O; Tarakji KG; Mehta A; Mick S; Grimm R; Wilkoff BL
    JACC Clin Electrophysiol; 2018 Nov; 4(11):1421-1428. PubMed ID: 30466846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transvenous extraction of permanent pacemaker and defibrillator leads: Reduced procedural complexity and higher procedural success rates in patients with infective versus noninfective indications.
    Archontakis S; Pirounaki M; Aznaouridis K; Karageorgopoulos D; Sideris K; Tolios P; Triantafyllou K; Gatzoulis K; Tousoulis D; Sideris S
    J Cardiovasc Electrophysiol; 2021 Feb; 32(2):491-499. PubMed ID: 33345428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution in transvenous extraction of pacemaker and implantable cardioverter defibrillator leads using a mechanical dilator sheath.
    Oto A; Aytemir K; Canpolat U; Yorgun H; Şahiner L; Kaya EB; Kabakçi G; Tokgözoğlu L
    Pacing Clin Electrophysiol; 2012 Jul; 35(7):834-40. PubMed ID: 22486778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.